Chemung Financial Corporation (CHMG)
Valuation Overview•Is Chemung Financial Corporation Overvalued or Undervalued?
Commands a premium valuation multiple over its peers, likely pricing in superior execution.
Moderate quality score of 52/100, reflecting stable operating margins and manageable leverage.
Analysts remain cautious, with consensus price targets indicating limited room for upside expansion.
Verdict: Average quality business weighed down by significant growth concerns.
Wall Street is cautious, forecasting potential downside alongside robust expected earnings growth. However, capital return yields remain modest, anchored by a strong, well-covered dividend yield.
CHMG demonstrates strong business quality with robust profitability and healthy margins. This is backed by a fortress balance sheet, holding significant net cash ($18M) and minimal debt risk.
The company maintains stable top-line performance however, earnings have severely contracted over the same period. Operating efficiency remains adequate with margins around 14.2%.
| Financial Metric | Trend (12Q) | Latest Qtr | 1Y Growth | 3Y CAGR | 5Y CAGR | 10Y CAGR |
|---|---|---|---|---|---|---|
| Revenue | $40.9M | -6.5% | — | — | +6.6% | |
| EBITDA | $11.8M | — | -17.3% | — | — | |
| Net Income | $7.7M | -36.2% | -19.3% | — | +4.8% | |
| EPS (Diluted) | $1.61 | -36.9% | -20.1% | -4.8% | +4.6% | |
| Free Cash Flow | $15.9M | +68.5% | +8.4% | +9.7% | — |
| Metric | TTM | 3Y Avg | 5Y Avg | 10Y Avg |
|---|---|---|---|---|
| Gross Margin | 64.2% | 65.9% | 77.5% | 83.2% |
| Operating Margin | 14.2% | 19.1% | 26.1% | 24.4% |
| Net Margin | 10.8% | 15.0% | 20.4% | 18.7% |
| FCF Margin | 31.4% | 23.8% | 28.7% | 28.9% |
| Quarter | EPS Est. | EPS Act. | Surprise | EPS | Rev |
|---|---|---|---|---|---|
| Q2'26Latest | $1.63 | $1.91 | +17.2% | ||
| Q1'26 | — | $1.61 | — | ||
| Q1'26 | $1.60 | $1.61 | +0.6% | ||
| Q4'25 | $1.68 | $1.62 | -3.6% | ||
| Q3'25 | $1.31 | $1.31 | +0.0% | ||
| Q2'25 | $1.22 | $1.26 | +3.3% | ||
| Q1'25 | $1.23 | $1.24 | +0.8% | ||
| Q4'24 | $1.13 | $1.19 | +5.3% |
Total return is +53.9% (1Y), outperforming the benchmark by +28.9%
| Period | Total Return | vs S&P 500 (Alpha) | Dividend Contribution |
|---|---|---|---|
| YTD | +31.5% | +22.2% | — |
| 1Y | +53.9% | +28.9% | +2.9% |
| 3YCAGR | +24.1% | +4.2% | +9.9% |
| 5YCAGR | +12.9% | +0.1% | +15.1% |
| 10YCAGR | +10.7% | -3.1% | — |
The S&P 500 is at 31.3x trailing P/E — Expensive relative to historical averages.
Quick answers to common questions about Chemung Financial Corporation (CHMG) valuation, health, and returns.
Based on peer relative multiples, Chemung Financial Corporation appears Expensive versus peers compared to industry peers.
Chemung Financial Corporation has multiple valuation anchors: Peer Relative Fair Value: $53.70 | Wall Street Analyst Target: $50.00 (implying -29.5% upside). A convergence of these signals offers higher conviction.
Chemung Financial Corporation displays fair financial health with a composite quality score of 52/100, supported by a Piotroski F-Score of 4/9, Return on Invested Capital (ROIC) of 5.0%.
Chemung Financial Corporation pays a 1.9% dividend yield, covered by a 42% payout ratio with 1 years of growth, supplemented by a 0.1% buyback yield.
Chemung Financial Corporation's current growth trajectory is Accelerating. The company achieved -6.5% 1Y revenue growth and -36.9% 1Y EPS growth, compared to its 3Y revenue CAGR of N/A.
Wall Street consensus is Hold based on 7 analysts, beating EPS expectations in 75% of recent quarters with a 2-quarter streak. The consensus price target represents a -29.5% change from current levels.
Investment risks for Chemung Financial Corporation include: -21.2% 1-year max drawdown. Volatility risk is characterized by a beta of 0.49x.
No. These computations are purely quantitative model outputs for informational purposes. They do not account for qualitative management shifts or macro events. Always consult a licensed RIA before buying or selling shares.
Disclaimer: This page is for informational purposes only and does not constitute financial advice. All valuation models, scores, and target estimates are automated computations under stated assumptions and should not be relied upon as the sole basis for any investment decision.